Tirzepatide 30 mg

TZ-2026-013Lot FLX-091726Analyzed October 26, 2026

Timeline

Ordered

October 18, 2026

Received

October 24, 2026

Analyzed

October 26, 2026

Sample

Name

Tirzepatide 30 mg

Expected

Tirzepatide

Amount

1 vial, lyophilized powder

Testing

Client

Bankroll Aminos

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

37.49mg

Label claim: 30 mg

Purity, how clean it is

99.8%

by HPLC-UV peak area

Chromatogram

HPLC-UV

18.86 min, Tirzepatide, 99.8%

Analyst Comments

White lyophilized powder, blue-cap vial, received sealed. Identity confirmed by co-injection with a tirzepatide reference standard.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 26, 2026

Verification Code

TZ-NR5N-R7TF

Verify at purilab.org/verify/TZ-NR5N-R7TF

Scan to Verify

TZ-NR5N-R7TF

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1